ProCE Banner Activity

HIV and STI Prevention in Cisgender Women: Studies from CROI 2023 Influencing My Practice in Eastern Europe

Clinical Thought

Read my commentary on key updates on HIV and STI prevention in cisgender women, including data on HIV preexposure prophylaxis from HPTN 084 and HPTN 084-01, as well as use of doxycycline postexposure prophylaxis.

Released: March 10, 2023

Expiration: March 08, 2024

Share

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Program Director Disclosure

Program Director

Justyna Kowalska, MD, PhD

Department of Adults’ Infectious Diseases
Medical University of Warsaw
Warsaw, Poland

Justyna Kowalska, MD, PhD, has no relevant financial relationships to disclose.